27 January 2025
27 January 2025
An international team, co-led by Adriana Sánchez-Danés, principal investigator of the Cancer and Stem Cell Biology Lab at the Champalimaud Foundation, in Lisbon, has shown for the first time the important role of Survivin – a protein that has key roles in regulating cell division and inhibiting apoptosis (programmed cell death) – in the initiation and formation of a basal cell carcinoma, the most common human skin cancer. Their results have now been published in the print edition of January 8, 2025, of the journal Cell Discovery.
The future of oncological surgery relies on the development of scientific research skills, and the Surgical Oncology Research Programme offers a unique opportunity for clinical and academic growth, with a personalised doctoral path, a flexible curriculum, and ample opportunities for professional development, mentorship, and networking.
17 January 2025
From groundbreaking scientific research to compassionate, patient-centered clinical care, the Foundation is committed to developing innovative solutions for complex challenges, all with the goal of improving lives and inspiring hope.
Founded in the beginning of the 21st century, it carries forward the visionary legacy of António Champalimaud, advancing science and healthcare for the greater good of humanity.
Join us in discovering how, together, we are shaping a brighter future.
20 January 2025 – 12:00
Champalimaud Foundation Auditorium
Conventional Dendritic Cells – Ecology, Diversity, and Functio
Carlos Minutti (Immunoregulation Lab)
Moderator: Cristina João (Myeloma Lymphoma Research Group)
14 January 2025
Osteosarcoma is a type of aggressive bone cancer that most commonly affects children and young adults between the ages of 10 and 20, during times of rapid bone growth. Although rare, it has a significant impact on young people and their families as treatment can require surgery or amputation. The cancer also has the potential to spread to other organs, most commonly the lungs. Because osteosarcoma is so genomically complex, it has been challenging to identify what genetic mutations drive the disease.
08 Jan. 2025
Breast Imaging, part of the Breast Unit at the Champalimaud Clinical Center in Lisbon, is looking for a Radiologist dedicated to breast diagnosis and intervention to join the Breast Imaging team, which consists of 4 radiologists fully dedicated to breast diagnosis and intervention.
12 December 2024
Precursor lesions of pancreatic cancer are very difficult to characterise with magnetic resonance imaging (MRI). But now, in a new study, researchers led by Noam Shemesh and Carlos Bilreiro – respectively head of the Preclinical MRI lab at Champalimaud Research and a doctor at the Champalimaud Clinical Centre’s Radiology Department – have shown, for the first time, that a particular form of MRI, called Diffusion Tensor Imaging (DTI), is capable of robustly detecting pre-malignant lesions in the pancreas.
02 Dec. 2024
- Responsible for clinical / patient data acquisition and management;
- Managing data for complex studies within agreed timescales;
- Responsible for implementing systems to monitor timeliness of data entry;
- Manage a team of data staff to ensure data is entered and site files are managed providing a high-quality data service to Principal Investigators and study teams. Responsible for clinical / patient data acquisition and management;
- Managing data for complex studies within agreed timescales;
04 December 2024
Cancer is one of the leading causes of death worldwide, and it brings with it significant emotional, social, economic, and public health challenges.
Prevention is a crucial tool in the fight against cancer. By identifying risks early, it not only saves lives and reduces suffering but also helps conserve valuable healthcare resources, both human and financial.